eu.reca, European Respiratory Cluster Antwerp, is an initiative of Frank Pieters, an internationally recognised expert in the respiratory field. His background includes market innovation and product development specifically related to inhalation at companies such as GlaxoSmithKline, Teva and Cipla. Through his own company, P&L Projects, he coaches various start-ups and contributes to the growth of diverse internationally oriented companies.
Also actively involved is the Provincial Development Agency (Provinciale Ontwikkelingsmaatschappij or POM) Antwerp. With the ambition of further reinforcing the position of the Province of Antwerp as a knowledge region, POM is focusing on accommodating growth companies. The Science Park University of Antwerp, which was developed by POM Antwerp, is thus geared towards attracting innovative companies in fields such as Life Sciences. The respiratory field was selected as a spearhead sector by the POM.
eu.reca is governed by an advisory board that reviews all activities for relevance and topicality for the respiratory field.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Galileilaan 15, Niel,flemish Region 2845,belgium
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- eureca.world
- Keywords
- respiratory, Life Sciences, Air pollution, Air quality, indoor air quality, outdoor air quality, airways, pneumology.
- HQ
- Niel, Flemish Region
Eu.reca Questions
Eu.Reca's website is eureca.world
Eu.Reca's LinkedIn profile is https://be.linkedin.com/company/eu-reca
Eu.Reca has
5 employees.
View email and phone details for 5
employees at Eu.Reca.
Eu.Reca's industry is
Hospitals and Health Care
Eu.Reca's top competitors are
Thema Invest Sa,
Wetenschapspark Universiteit Antwerpen,
Lamb,
At.las Atmp,
Bluepoint Antwerp,
Neumax Lusitana,
Modus Sa,
Corealis Pharma Inc.,
Archimed,
Cosmade Belgium.
Eu.Reca's categories are Hospitals and Health Care
Eu.Reca's founding year is 2018
